Navigation Links
IRIDEX Announces Fourth Quarter and Full Year 2011 Conference Call and Release Date
Date:2/23/2012

MOUNTAIN VIEW, Calif., Feb. 23, 2012 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that it will release its fourth quarter and full year 2011 financial results after the market closes on Thursday, March 1, 2012.  In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Thursday, March 1, 2012 to discuss the results of the quarter and full year and other business developments.

Interested parties may access the live conference call via telephone by dialing (800) 762-8779 U.S. or (480) 629-9771 (International) and quoting Conference ID 4517801, or by visiting the Company's website at www.iridex.com.   A telephone replay will be available beginning on Thursday, March 1, 2012 through Thursday, March 8, 2012 by dialing (800) 406-7325 (US) or (303) 590-3030 (International) and entering Access Code 4517801.

About IRIDEX
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into 107 countries. For further information, visit the Company's website at http://www.iridex.com.


'/>"/>
SOURCE IRIDEX Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. IRIDEX Introduces New ENT Laser Delivery Devices at AAO-HNSF Annual Meeting
2. IRIDEX Introduces Modular Multi-Wavelength Laser Solution at the American Academy of Ophthalmology
3. IRIDEX Introduces IQ 532 Dual Port Green Laser System at the American Academy of Ophthalmology
4. Ruediger Naumann-Etienne Appointed to IRIDEX Board of Directors
5. IRIDEX Announces Fourth Quarter and Full Year 2009 Conference Call and Release Date
6. IRIDEX Reports Fourth Quarter and Full Year 2009 Financial Results
7. IRIDEX Announces First Quarter 2010 Conference Call and Release Date
8. IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems
9. IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery
10. IRIDEX Announces Second Quarter 2010 Conference Call and Release Date
11. IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013   Accuray Incorporated ... publication of study results involving hundreds of prostate ... System, the most widely used form of prostate ... 304 patients for a median of 5 years, ... that 97 percent of patients with low-risk and ...
(Date:5/21/2013)... ORLANDO, Fla. , May 21, 2013 /PRNewswire/ ... and safety results from the global Phase 3 ... protease inhibitor simeprevir (TMC435) led to sustained virologic ... (SVR12) in 79 percent of treatment-experienced genotype 1 ... disease, including all stages of liver fibrosis, when ...
(Date:5/21/2013)... , May 21, 2013 Abaxis, Inc. ... analysis systems, announced today that Martin Mulroy ... the Stifel Annual Dental & Veterinary Conference on Wednesday, ... will be held at Le Parker Meridien Hotel in ... About Abaxis Abaxis develops, manufactures, markets and ...
Breaking Medicine Technology:New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2
... Sept. 9, 2011 Valeant Pharmaceuticals International, Inc. (" Valeant ... of Afexa Life Sciences Inc. (" Afexa ") its offer ... friendly offer (the " Offer ") for all of the ... at a price of C$0.71 in cash per Common Share. ...
... YORK, Sept. 8, 2011 NeoStem, Inc. (NYSE ... "Company"), an international biopharmaceutical company with a focus ... presenting at three upcoming September conferences: the Rodman ... Commercialization Summit, and the JMP Securities Healthcare Conference. ...
Cached Medicine Technology:Valeant Pharmaceuticals Announces Mailing of Offer and Take-Over Bid Circular to Shareholders of Afexa 2Valeant Pharmaceuticals Announces Mailing of Offer and Take-Over Bid Circular to Shareholders of Afexa 3Valeant Pharmaceuticals Announces Mailing of Offer and Take-Over Bid Circular to Shareholders of Afexa 4NeoStem Announces Participation in Multiple September Conferences 2NeoStem Announces Participation in Multiple September Conferences 3
(Date:5/21/2013)... A new study appearing in the current ... cells harvested from fat (adipose) are more potent than ... the body’s immune system. , The finding could ... adipose tissue-derived stem cells (AT-SCs) are far more plentiful ... and can be collected from waste material from liposuction ...
(Date:5/21/2013)... Idaho (PRWEB) May 21, 2013 The ... 26 million people in the United States of America ... patients are at a great risk of developing peripheral ... lead normal lives. The ADA further goes on saying ... 20 years and around 2 million new cases are ...
(Date:5/21/2013)... Australia (PRWEB) May 22, 2013 About ... made the Fertility Clinics industry one of ... industry assists patients who are unable to conceive naturally ... and popular of which is in-vitro fertilisation (IVF) cycles. ... IVF cycles in Australia has increased by 4.4% per ...
(Date:5/21/2013)... (HealthDay News) -- Aggressive treatment for prostate cancer ... with underlying medical conditions, a new study finds. ... radiation and radioactive seed implants, can cause serious ... and bowel problems, explained researchers from the University ... found that older patients with slower growing forms ...
(Date:5/21/2013)... University in St. Louis announced today that it ... funded by the Bill & Melinda Gates Foundation. ... environmental & chemical engineering, will pursue an innovative ... Killing of Parasite Eggs by Probiotic Organisms." , ... explore ideas that can break the mold in ...
Breaking Medicine News(10 mins):Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 2Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 3Health News:Neuracel Aims to Reduce Peripheral Neuropathy Pain 2Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Age, Other Illnesses May Make Prostate Cancer Treatment Unnecessary 2Health News:Gates Fellowship addresses parasite infection in developing world 2
... You Are Still Doing Only for OthersSEYMOUR, Tenn., May 1 ... to honor their mothers for all the hard work and ... family first everyday of the year, many times over themselves, ... day designed to celebrate a mother,s love and support can ...
... Boston, MAFollowing the declaration of a public health emergency due ... the Harvard Opinion Research Program at the Harvard School of ... about the outbreak, how they are responding and what they ... about the outbreak , The survey finds that nearly half ...
... Ronald McDonald House Acknowledges Decades of ... more than necessary to keep the non-profit segment ... Ronald McDonald House of Delaware is making sure ... Volunteer Recognition Wall is set to premiere this ...
... 8th Annual National Day to Prevent Teen PregnancyWASHINGTON, May 1 ... rate in the United States increased 5% between 2005 and ... Campaign to Prevent Teen and Unplanned Pregnancy will examine why ... to try to reverse the trend.The forum will take place ...
... National Osteoporosis Foundation calls on Moms to Address Bone Health ... that generations of women have passed on to their loved ... knowledge about health -- especially information about bone health and ... Gift from Mothers to Daughters as the theme for ...
... benefitSAINT PAUL, Minn., May 1 Second Harvest ... honored David Nasby, former vice president of the ... first food bank network, with its inaugural Hunger ... contributions to hunger relief."I am humbled to receive ...
Cached Medicine News:Health News:Feel Like Everyone Forgets Mother's Day Is for Mothers? 2Health News:Feel Like Everyone Forgets Mother's Day Is for Mothers? 3Health News:Survey finds nearly half of Americans concerned they or their family may get sick from swine flu 2Health News:Survey finds nearly half of Americans concerned they or their family may get sick from swine flu 3Health News:Artist Contributes to Volunteer Recognition 2Health News:Forum Explores Solutions to the Rise in the Teen Birth Rate 2Health News:Forum Explores Solutions to the Rise in the Teen Birth Rate 3Health News:Family History is Key Risk Factor in Developing Osteoporosis 2Health News:Family History is Key Risk Factor in Developing Osteoporosis 3Health News:Second Harvest Heartland Honors Hunger Hero David Nasby 2Health News:Second Harvest Heartland Honors Hunger Hero David Nasby 3
2.5x8mm Spatula Combined with 8mm Blade; in stainless steel....
0.6mm Tip x10mm Shaft, Straight Shaft, 90 Degree Hook at Tip; overall length 120mm; in Titianium....
Bend with "H" Shaped Tip, Right; Stainless Steel....
... Perfusion Catheter is indicated for ... portion of a coronary artery ... the purpose of improving myocardial ... are also designed to provide ...
Medicine Products: